Exploring the Impact of Medication Confounders on Determining Death by Neurologic Criteria: An International Survey Investigating Practice Variation
The purpose of this survey is to elucidate current practices and perceptions surrounding medication confounders in brain death determination. Specifically, this survey seeks to understand:
- Who may be the individuals assessing potential drug confounders in brain death determination.
- Whether there is a formal or informal guideline or institutional policy/procedure that encompasses potential drug confounders in brain death and how to account for them.
- Whether a requirement exists for medication review prior to brain death determination.
- Whether ancillary testing, reversal agents or serum drug concentrations are utilized in patients in whom a medication confounder may be a concern.
The targeted audience for this survey is physicians, advanced practice providers, pharmacists and nurses who practice at institutions where patients may undergo brain death determination.
Duration: 10 minutes
Contact: Devin Holden
Survey Closes: June 30, 2024
Take the Survey
The Variability in Use and Protocols for Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage
The purpose of this study is to understand the variability in use and protocols for intrathecal nicardipine in aneurysmal subarachnoid hemorrhage patients. Study activities will include the completion of a brief survey which includes questions about clinical treatment decisions and protocols.
Target Audience: Attendings who treat subarachnoid hemorrhage
Duration: 5-10 minutes
Contact: Rachel Beekman
Survey Closes: March 1, 2024
Take the Survey
Intubation Practices in Neurocritical Care
The University of Michigan is conducting a research study to understand how intubation is performed in Neurocritical Care Units in the US. We are asking you to complete a voluntary survey that will take approximately 10-15 minutes. There is a small risk that your personal information could be revealed, but we will take steps to protect your privacy and will not share any identifiable information in any research publications. Your participation is voluntary, and you can stop the survey at any time without penalty. There is no compensation for participating, but your responses may help us to improve our understanding of intubation practices in the US. The University of Michigan IRB has approved this study.
Target Audience: Attending physicians, fellows, mid-level providers and residents
Duration: 10-15 minutes
Contact: Rameez Merchant
Survey Closes: March 30, 2024
Take the Survey
Ketamine for Refractory Status Epilepticus: A Survey of Practices and Perceptions
The purpose of this study is to gather information regarding the use of ketamine for refractory status epilepticus, including common practices and perceptions. Ketamine is an adjunct anesthetic sometimes used in the setting of RSE, though the frequency of use, typical starting and titration doses, duration, time of initiation, and other practices and perceptions remain largely unknown.
Target Audience: Physicians, advanced practice providers, pharmacists, nurses, and researchers caring for patients with refractory status epilepticus
Duration: 10 minutes
Contact: Gabe Fontaine
Survey Closes: April 1, 2024
Take the Survey